FOS and myelodysplastic syndrome: In contrast, in the presence of emetine, MDS showed significantly lower FOS mRNA levels remaining at 25 and 45 min (34.8±16.7% and 37.9±25.5%, respectively) than the healthy controls (70.6±15.1%, P<0.01 and 76.7±19.8%, P<0.01).